Skip to main content
JAMA Network logoLink to JAMA Network
. 2017 Oct 9;177(11):1703. doi: 10.1001/jamainternmed.2017.6218

Typographical Errors in the Table

PMCID: PMC8177347  PMID: 29052708

In the Original Investigation titled “Research and Development Spending to Bring a Single Cancer Drug to Market and Revenues After Approval,”1 published online September 11, 2017, there were 2 typographical errors in the Table. In row 1 of column 4, the date was changed from January 2002 to January 1992. In row 9 of the last column, 7689.1 was changed to the correct value of 6789.1. This article has been corrected online.

Reference

  • 1.Prasad V, Mailankody S. Research and development spending to bring a single cancer drug to market and revenues after approval [published online September 11, 2017]. JAMA Intern Med. doi: 10.1001/jamainternmed.2017.3601 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from JAMA Internal Medicine are provided here courtesy of American Medical Association

RESOURCES